Vyzulta

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were surging nearly 14 percent after the open Tuesday after the company reported first-quarter results and announced a name change to Bausch Health Companies Inc. that takes effect in July.  What Happened Canada-based Valeant said it...

Amid “overstated” legal issues and in the aftermath of natural disaster, Valeant Pharmaceuticals Intl Inc (NYSE: VRX) may profit from a positive catalyst this week, according to H.C. Wainwright & Co. Analyst Raghuram Selvaraju reiterated a Neutral rating on the stock with a $17...